Based on initial studies in animal models1 and human T-cell clones2 and bronchoscopic studies in patients with mild steroid-naive asthma,3,4 it has been viewed as a disease driven by activated TH2 cells producing the type 2 interleukins IL-4, IL-5, and IL-13. The gene discussed is IL13; the disease is asthma.